ProKidney Corp. (PROK) NASDAQ

1.63

-0.17(-9.44%)

Updated at December 27 01:34PM

Currency In USD

ProKidney Corp.

Address

2000 Frontis Plaza Blvd.

Winston-Salem, NC 27103

United States of America

Phone

336 999 7028

Sector

Healthcare

Industry

Biotechnology

Employees

163

First IPO Date

June 30, 2021

Key Executives

NameTitlePayYear Born
Dr. Bruce Culleton M.D.Chief Executive Officer & Director657,9351968
Mr. James Coulston CPAChief Financial Officer533,1521977
Mr. Todd C. Girolamo Esq., J.D., M.B.A.Chief Legal Officer & Secretary541,5861965
Dr. Timothy A. Bertram D.V.M., Ph.D.Founder1.46M1955
Dr. Ulrich Ernst Ph.D.EVice President of Science and Technology01962
Dr. Darin J. Weber Ph.D.Chief Reg. Off, SVice President and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access01968
Ms. Anu BiswasSenior Vice President of Manufacturing & Operations0N/A
Ms. Carla PoulsonChief People Officer0N/A
Dr. Joseph M. Stavas M.D., M.P.H.SVice President of Clinical Affairs0N/A
Mr. Nikhil L. Pereira-KamathChief Business Officer0N/A

Description

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.